Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ZELAPAR safely and effectively. See full prescribing information for ZELAPAR.ZELAPAR® (selegiline hydrochloride) orally disintegrating tabletsInitial U.S. Approval: 2006
Medication labelWhy this: Advisory · dailymed-prescription
ZELAPAR is indicated as an adjunct in the management of patients with Parkinson’s disease being treated with levodopa/carbidopa who exhibit deterioration in the quality of their response to this therapy. There is no evidence from controlled studies that ZELAPAR has any beneficial effect in the absence of concurrent levodopa therapy [see Clinical Studies (14 )].
- generic_name
- selegiline hydrochloride
- product_names
- SELEGILINE HYDROCHLORIDE
- ndc
- 0187-0453, 0187-0453-02, 0187-0453-03
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en